Previous
Previous

Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

Next
Next

89bio, Inc. Announces Upsized Pricing of $275 Million Public Offering of Common Stock